Hacker News new | ask | show | jobs
by dominotw 9 days ago
i remember so much excitement around radioligand therapies like 177Lu-PSMA-617 being better than chemo and with way way less sides . And great improvements in pfs and os.

didnt seem to have lived up to the promise. seemed to have accelerated prostate cancer for my father who passed away in mere three months after first dose.

1 comments

Same. 177Lu-PSMA-617 caused severe blood cell shortage and within a month after the second dose my dad died.

Immunotherapies on the other hand seems to work wonders for many who respond to it. I regret for not trying it.